Press Releases

Coloplast Streamlines Collaboration with Cloud-based Life Sciences Platform for Regulated Content Management

Danish medical device company upgrades to Veeva Vault for regulated content management

PLEASANTON, CA — March 8, 2016 — Coloplast, a Denmark-based medical device maker, selected Veeva Vault as its regulated content management system. Recognized as one of the most innovative companies in the world by Forbes, Coloplast chose Veeva’s industry specific platform so that its employees can efficiently and compliantly collaborate and share content.

Coloplast now centrally manages all of its design history files with Veeva Vault, migrating 85,000 documents from its previous content management system in under 13 weeks. A driver in the decision to move to a new system was the fact that Veeva offers industry cloud solutions tailored to meet the unique needs of life sciences.

“It was difficult to find a content management system that met our compliance requirements without heavy customization. As a life sciences-specific platform, Veeva Vault had all of the industry functionality we needed,” said Orit Magyar, head of quality systems and processes at Coloplast.

Coloplast required a system that supported compliance and was secure, yet quickly and easily accessible across a range of devices. Additionally, performing and documenting all elements of Installation Qualification (IQ) and Operational Qualification (OQ) with each release dramatically decreased Coloplast’s validation efforts, reducing maintenance costs and compliance risk.

“We needed a scalable, global, and easy-to-search document management solution that would adapt to our expanding business needs and meet multiple stakeholder requirements,” Magyar explained. “Veeva Vault is transforming how our employees access and manage critical documentation.”

“We are already seeing faster document approval and tighter control. Moreover, the ability to have real-time visibility through dashboards and reports gives us a window to see where content stands, so bottlenecks or problems can be resolved immediately – not weeks later,” said Magyar.

Usability was another key factor in Coloplast’s selection of Veeva Vault. “Veeva Vault’s intuitive interface makes it easy for new users. The need for extensive training is a thing of the past – literally, our teams had just a few hours of e-learning and were good to go,” said Magyar. “A simple-to-use system motivates staff and partners to take full advantage of it, which ultimately leads to increased compliance.”

Additional Information
For more on Veeva Vault, visit:
Stay updated on the latest Veeva news on LinkedIn:
Follow @veevasystems on Twitter:
Like Veeva on Facebook:

About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 400 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America. For more information, visit

Forward-looking Statements
This release contains forward-looking statements, including the market demand for and acceptance of Veeva’s products and services, the results from use of Veeva’s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the company’s filing on Form 10-Q for the period ended October 31, 2015. This is available on the company’s website at under the Investors section and on the SEC’s website at Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.


Public Relations
Veeva Systems Inc.